Zimmer Biomet Acquires Ortho Transmission, LLC and Assets for Pioneering Technology to Restore Limb Amputee Patients
Innovative new limb prosthesis technology developed by U.S. military surgeon would support direct skeletal attachment of a transdermal device
Currently available systems for limb amputee patients involve the fastening of a limb prosthesis to a molded socket that fits over the patient's residual limb, which must be replaced periodically over the course of a lifetime. Transcutaneous systems are designed to eliminate the skin-to-socket interface and avoid common prosthetic complications, such as soft tissue irritation, sores, infections and joint pain, while reducing the extra expenditure of energy the patient must exert in order to walk. Direct skeletal attachment of a limb prosthesis with a transcutaneous device may also improve the patient's ability to sense the position of the prosthetic1.
Ortho Transmission's transcutaneous osseous integrated skeletal implant technology was developed by Dr.
"Transcutaneous osseous integrated technology represents a fundamental innovation in limb replacement, and
The Company aims to leverage designs acquired from Ortho Transmission in order to offer this technology to patients, beginning with a clinical trial. Ortho Transmission invested more than ten years into pre-clinical research, animal studies2 and human biomechanical analysis to address the limitations of conventional molded socket technology with a transcutaneous osseous integrated skeletal implant3 that has been optimized using advanced Finite Element Analysis design software as well as mechanical testing.
"We are truly excited to partner with the world leader in musculoskeletal innovation and we look forward to accelerating this ongoing work in order to bring this pioneering technology to market," said DC Hoffman, General Manager, Ortho Transmission.
About Zimmer Biomet
Founded in 1927 and headquartered in
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow
Cautionary Statement Regarding Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "aims," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negatives of such terms or other variations on such terms or comparable terminology. Forward-looking statements include, but are not limited to, statements concerning products and services offered by
2 Hugate R, Clarke R, Hoeman T, Friedman A. Transcutaneous Implants in a Porcine Model: The Use of Highly Porous Tantalum.
3 Drygas KA, Taylor R, Sidebotham CG, Hugate R, McAlexander H. Transcutaneous tibial implants: a surgical procedure for restoring ambulation after amputation of the distal aspect of the tibia in a dog. Vet Surg. 2008;37(4):322-7.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zimmer-biomet-acquires-ortho-transmission-llc-and-assets-for-pioneering-technology-to-restore-limb-amputee-patients-300229103.html
News Provided by Acquire Media